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Abstract: Malnutrition continues to threaten the lives of millions across the world, with children
being hardest hit. Although inadequate access to food and infectious disease are the primary causes of
childhood malnutrition, the gut microbiota may also contribute. This review considers the evidence
on the role of diet in modifying the gut microbiota, and how the microbiota impacts childhood
malnutrition. It is widely understood that the gut microbiota of children is influenced by diet,
which, in turn, can impact child nutritional status. Additionally, diarrhoea, a major contributor
to malnutrition, is induced by pathogenic elements of the gut microbiota. Diarrhoea leads to
malabsorption of essential nutrients and reduced energy availability resulting in weight loss, which
can lead to malnutrition. Alterations in gut microbiota of severe acute malnourished (SAM) children
include increased Proteobacteria and decreased Bacteroides levels. Additionally, the gut microbiota
of SAM children exhibits lower relative diversity compared with healthy children. Thus, the data
indicate a link between gut microbiota and malnutrition in children, suggesting that treatment of
childhood malnutrition should include measures that support a healthy gut microbiota. This could
be of particular relevance in sub-Saharan Africa and Asia where prevalence of malnutrition remains
a major threat to the lives of millions.
Keywords: severe acute malnutrition; gut microbiota; children; infants; breastfeeding; diet
1. Introduction
The prevalence of malnutrition in children under five years of age in developing na-
tions remains alarming. The World Health Organization (WHO), United Nations Children’s
Fund (UNICEF) and the World Bank Group reported that globally in 2017, 150.8 million
(22.2%) children under five years of age were stunted, with wasting threatening the lives of
7.5% (50.5 million) of children [1]. Africa and Asia are the continents most affected by such
malnutrition, bearing 39% and 55% (respectively) of global stunting prevalence in children
under five. It is estimated that about half of all under-five-year-old childhood deaths are
as a result of stunting (chronic malnutrition), culminating in about 3 million child deaths
every year [1]. The most common and immediate causes of malnutrition/undernutrition
in children are inadequate dietary intake and disease (such as diarrhoea), according to
the UNICEF conceptual framework of the causes of malnutrition [2], resulting in deficient
growth and development. Although inadequate access to sufficient nutrition is the main
cause of malnutrition, gut microbiota have also been implicated in this condition [3,4]. Al-
terations in the gut microbiota, characterized by increases in the phylum Proteobacteria and
decreases in Bifidobacterium and Lactobacillus species, are associated with episodes of diar-
rhoea [5–7], and diarrhoea is a major causative factor in malnutrition of children, especially
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those in low-income countries [8,9]. The causes of malnutrition, together with strategies to
counteract malnutrition, are of significant public health interest, and manipulation of the
gut microbiota provides a potential opportunity for alleviation of malnutrition [10].
The scope of this review therefore includes the role of diet in modifying the gut
microbiota and how the gut microbiota impacts malnutrition in children. It also considers
how the use of ready-to-use therapeutic foods (RUTF) in the treatment of severe acute
malnutrition changes the gut microbiota of malnourished children.
2. The Human Gut Microbiome in Health and Disease
2.1. In Health
The human gastrointestinal tract harbours microbial populations consisting of 1013–1014
cells [11], but the density and composition differ markedly between compartments. In the
stomach of healthy people, the bacterial load is relatively low at 102 colony-forming units
(CFUs)/mL of contents, but rises in the small intestine to 102–104 CFUs/mL [12]. However,
the highest levels (1012 CFUs/mL) are found in the colon, where conditions (pH 5.5–7, slow
transit time, and high nutrient availability) are highly conducive for bacterial growth [13].
The colonic bacteria are mainly anaerobic [12] and carry out a range of metabolic pro-
cesses, some of which are considered of benefit to the host. For example, gut microbes
ferment indigestible carbohydrates, generating short-chain fatty acids (SCFAs) for the host.
These SCFAs have been reported to have several health benefits to the host, including the
provision of energy for epithelial cells and lowering the pH of the intestinal lumen, thus
restricting growth of some pathogens [14,15] and providing an anti-inflammatory effect
to the host [16]. The gut microbiota has also been observed to play an important role in
absorption, storage and expenditure of energy from the diet [17–19] as well as synthesis
of vitamins K and B12 [20,21]. Energy intake and expenditure are predominantly coordi-
nated by the brain. The gastrointestinal tract (GI), the first site of contact with ingested
food, sends important signals (through neuroendocrine and neuroimmune systems) to
the brain regarding the composition and size of incoming food [22]. Furthermore, the
gut microbiota is involved in the production of metabolites, including SCFAs, secondary
bile acids, tryptophan and even neurotransmitters; these play an important role in gut
barrier function and also in gut–brain signalling [23,24]. The gut–brain axis is important
for maintaining energy balance and controlling energy expenditure, and has also been
observed to impact on cognitive function [25]. Such benefits have led to a growing interest
in the use of prebiotics, probiotics and other dietary modifications to modulate the gut
microbiota to improve nutrition and health [26].
The role of the gut microbiota of newborns in growth and development may be
dependent on the acquired microbial composition [27]. Recent metagenomic analysis of
the gut microbiota of infants suggests that in addition to the composition, the functional
potential of the microbiota plays a significant role in the nutritional status of the infant.
For instance, the development (transmitted from the mother) of bile acid and starch
metabolism bacteria may impact nutrient absorption and therefore, affect growth and
development of infants [28,29]. In breastfed infants, the gut microbiota is dominated by
Bifidobacterium longum subsp. infantis, which is tailored towards the metabolism of human
milk oligosaccharides (HMO) [30,31]. For infants fed on formula milk, infant formulae are
commonly fortified with prebiotics so as to confer similar beneficial components as those
found in breastmilk [32–34]. Prebiotics are “substrates that are selectively utilized by host
microorganisms conferring health benefits to the host” [35]. The common prebiotics used
in infant formula are short-chain galacto-oligosaccharides (GOS) and long-chain fructo-
oligosaccharides (FOS). These prebiotics have been shown to beneficially alter the gut
microbiota of infants by selectively enhancing the growth of Bifidobacterium and lowering
the abundance of Enterococcus and Escherichia coli [36,37]. However, GOS and FOS are
structurally different from HMO [38] and so do not entirely replicate the beneficial effects of
HMOs on the infant gut microbiota, for example, on a species level [34,39,40]. Nevertheless,
it has been noted that an infant diet supported by prebiotic formula results in fewer
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infections than a placebo formula does, and so non-HMO prebiotics appear to have a
positive impact in infants [41].
Probiotics are defined as “live microorganisms that, when administered in adequate
amounts, confer a health benefit on the host” [42]. It is now well established that probiotics
can modulate the gut microbiota of the host in a beneficial fashion [43–45]. For instance,
the addition of probiotics to infant formula has been known to confer numerous benefits to
the infant, including the improvement of gut health and immunity, countering the growth
of harmful bacteria (pathogens) in the gut and enhancing overall host immune and health
status [43]. Moreover, the addition of probiotics including Lactobacillus reuteri, Lactobacillus
acidophilus, Bifidobacterium longum, Bacillus clausii and Bifidobacterium lactis in infant formula
has been shown to reduce risks associated with diarrhoea resulting from antibiotic use
and the symptoms of colic [46–48]. In contrast, numerous studies have failed to find any
effect of probiotics on diarrhoea outcomes in children [39,49,50]. Indeed, a recent Cochrane
review based on large clinical trials with low risk of bias [51] reported little or no effect
of probiotics in the reduction of diarrhoea. Such contradictory results are likely linked to
the use of different probiotics and target populations. Given the contrasting evidence on
the use of probiotics in the management of diarrhoea in children, there remains a need for
targeted large-scale trials to follow on from the promising findings of specific probiotics
that improve diarrhoea outcomes, especially in children.
2.2. In Disease
There is evidence linking the gut microbial community to a range of diseases and
disorders, including inflammatory bowel disease (IBD), mood disorders, obesity, autism
and psoriatic arthritis [52–57], though further research is needed to ascertain the causal
link between the gut microbiota and such diseases. In some of these conditions, interven-
tions that impact the gut microbial community have led to improvement of symptoms,
further supporting a role for the microbiota [58–60]. An altered gut microbiota can be
caused by environmental factors such as antibiotic use, diet and stress, as well as genetic
factors. These changes can impair the ability of the gut microbiota to maintain good health
and may allow the growth of potentially pathogenic bacteria (e.g., Clostridioides difficile),
leading to production of metabolites that may cause a disease state in the host [61]. The
relative abundance of bifidobacteria in faecal samples of normal-body-weight children
was found to be higher than in overweight children of the same age bracket (7 years old).
In contrast, Staphylococcus aureus levels were higher in the overweight children than in
those with normal body weight [56]. In addition, a recent study reported an increased
abundance of Firmicutes and a reduction in bifidobacteria in the gut microbiota of over-
weight and obese children [62]. Furthermore, it has been observed that children who
became overweight/obese at age 10 years had significantly higher levels of Bacteroides
fragilis in early infancy (3 to 6 weeks after birth) than those whose body weight remained
normal [63]. These studies thus indicate that the microbial community of children may
differ according to BMI, suggesting that the microbiota may have a part to play in weight
gain, for example, through energy salvage. However, caution is required when considering
causal links between the gut microbiota and obesity, as recent meta-analyses failed to find
variations in the taxonomic microbial compositions of obese and lean adults, suggesting
that microbiota differences observed in other studies could be related to factors such as
diet [64–66]. Several other conditions, including eczema, asthma, inflammatory bowel
disease (IBD) and type 1 diabetes, in infants and young children have been linked to
differences in the gut microbiota. For instance, some studies show that infants with eczema
have a significant reduction in relative abundance of Bifidobacterium, Blautia, Coprococcus,
Eubacterium and Propionibacterium species [67] as well as a reduction in intestinal microbial
population diversity [68,69]; although it is worth noting that in healthy infants, there is
low microbiota diversity predominated by bifidobacteria. Moreover, an analysis of faecal
microbiota of infants (1 to 11 months old) revealed that gut microbiota alteration promotes
the disfunction of CD4+ T cells, which is linked to atopy in children [70]. Further, many
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studies have reported the gut microbiota to be altered in IBD [71–74], with an increase
in Enterobacteriaceae being particularly prominent [75]. In addition, it has been found
that children with prediabetes have higher levels of intestinal Bacteroidetes than healthy
controls [76].
Thus, there is much evidence to suggest that the gut microbiota provides numerous
health benefits to children, whilst an altered balance, as characterized by altered abundance
of key species (e.g., pathogenic groups such as Clostridioides difficile), can be associated
with negative health outcomes. However, one drawback of focusing on changes in the
microbiota is that there is a difficulty in determining the clinical relevance of such changes,
and so it remains unclear to what degree the gut microbiota contributes to malnutrition in
children (see Section 4.3).
3. Diet and Gut Microbiota in the First 1000 Days of Life
3.1. Factors Affecting the Gut Microbiota of Infants
The first major microbial colonization of the human gut occurs at birth, with composi-
tion subsequently changing over time. A number of factors affect microbial colonization
of the gut after birth, including gestational age, mode of delivery, maternal body mass
index (BMI) and gut microbiota, infant feeding practices, antibiotic exposure, infant ge-
netics, random exposure to microbes in the environment and the number of siblings; see
Figure 1 [77–81]. Additionally, the type of delivery (vaginal or caesarean delivery) is an
important factor that determines the early colonizers of the gut of newborns. Children
who are born through normal vaginal birth (NVB) initially receive their gut microbiota
from maternal vaginal and faecal sources, whilst those born through caesarean section
are initially colonized by microbiota related to the mother’s skin [78,82–84]. In a recent
longitudinal study, delayed microbiota colonization and significant taxonomic differences
were observed for caesarean deliveries compared to vaginal deliveries in infants during
their first year, although such differences were lessened 5 months after birth [85]. Moreover,
a recent clinical study on the effect of mode of delivery on gut microbiota composition [86]
showed an enrichment of Bifidobacterium spp. and a reduction in Klebsiella and Enterococcus
spp. in the gut microbiota of vaginally delivered infants compared to infants born by
caesarean section. This has also been shown in a more recent study [87] where infants born
by caesarean section were found to be less likely to have B. thetaiotaomicron or B. fragilis in
their gut microbiota. Additionally, a systematic review on the effect of mode of delivery
on the gut microbiota of infants indicates a significant difference between vaginal- and
caesarean-delivered children in the first 3 months, although the mode of delivery had
less impact later in infancy (6–12 months) when complementary foods are usually intro-
duced [88]. Furthermore, a longitudinal cohort study observed no differences in the gut
microbiota between caesarean- and vaginal-delivered babies beyond 6 weeks of birth [28].
These studies indicate that the impact of delivery mode on the gut microbiota is lessened
or lost as time progresses.
3.2. Impact of Breastfeeding on the Infant Gut Microbiota
Apart from being a source of energy and vital nutrients for infants, breastmilk also con-
tains a diverse microbiome and oligosaccharides with prebiotic properties [81]. However,
the human milk microbiome varies in response to maternal BMI, geographical location,
duration of pregnancy, lactation and mode of delivery [77–79]. Many butyrate-producing
bacteria such as Roseburium and Eubacterium have recently been demonstrated to grow
on complex HMO [84]. In addition, Bifidobacterium and Lactobacillus spp. are present in
breastmilk, and these are also found in maternal and neonatal faeces [82,83], which sug-
gests their potential transmission from mother to child through breastfeeding [85]. These
groups of bacteria have long been noted for their beneficial role in inhibiting pathogen
colonization and in the production of vitamins, the modulation of the immune response
and the maintenance of intestinal barrier function [88–90]. B. longum subsp. infantis and
Lactobacillus acidophilus have been observed to be higher in abundance in the gut microbiota
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of breast-fed compared with formula-fed infants, whereas the abundance of C. difficile,
Enterobacter cloacae, Citrobacter spp., Granulicatella adiacens and Bilophila wadsworthia is
higher for formula-fed compared with breast-fed infants. Additionally, Ruminococcaceae,
Bacteroides spp. and Lachnospiraceae of the Clostridia order are of raised abundance in
the gut microbiota of infants on complementary feeding [91–94]. A recent clinical study
observed an enrichment of Bifidobacterium and Bacteroides spp., and a lower abundance
of Streptococcus and Enterococcus spp., in the gut microbiota of breast-fed compared with
formula-fed infants [95]. In addition, as indicated above, breast milk has been observed
to contain bifidobacteria and to promote a bifidogenic effect [83]. Thus, breastfeeding has
a major impact on the composition of the infant gut microbiota, driving a predominance
of bifidobacteria, during the first year of life [96]. It is also becoming evident that initial
feeding practices and their resulting impact on the gut microbiota of infants have both
short- and long-term effects on health in later childhood [41,56,97]. This was shown in
a placebo-controlled, double-blinded study [98] where infants at risk of atopy were fed
prebiotic-supplemented formula (containing 0.8 g/100 mL GOS/FOS) or a control formula
(containing 0.8 g/100 mL maltodextrin) during the first 6 months after birth. They were
then followed until age 5 years. The prebiotic-supplemented group had significantly lower
incidence (five-year cumulative incidence) of allergic and atopic dermatitis manifestation
compared with the control group [98]. This study emphasizes the long-term impact of
early life feeding practice on the gut microbiota and health in children.
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3.3. Effect of Diet on the Gut Microbiota of Infants and Young Children
There is an increase in infant gut microbiota diversity after the age of 6 months when
complementary foods (with high protein and fibre) are introduced to the diet, indicating a
transition to a more complex icrobiota [92,99]. Thus, by 3 years of age, the gut microbiota
assumes an adult-like composition [20,93,100], although other reports suggest that the gut
microbiota does ot become adult-like until the age of 5 years [101–104]. As noted above,
the major driver of gut microbiota shift in infants is the introduction of complementary
feeding during the first years [92]. For example, a randomised control trial sh wed that the
introduction of complementary feeding (including cereal, fruit a d meat) l d to increas d
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gut microbiota diversity [105]. In addition, it was previously shown that the introduction
of complementary feeding in infants results in changes in the gut microbiota with increases
in the genera Bacteroides and Prevotella [100,106]. Moreover, a comparative study of the
gut microbiota of children (1 to 6 years old) in a rural area of Burkina Faso (BF) and an
urban area of Italy revealed higher Actinobacteria and Bacteroidetes levels and lower
Firmicutes and Proteobacteria numbers in the rural BF children relative to the urban
Italian children. However, there were no differences in the microbiota between the two
populations during the period of exclusive breastfeeding. Thus, the differences in the gut
microbiota appeared to be associated with the differences in postweaning diets; the diets of
the BF children were higher in dietary fibre and lower in fat and calories, and that of the
European (EU) children was higher in fat, sugars and animal protein but lower in fibre [107].
The distinct microbiomes of the two groups of children likely impacts host metabolism
and health; for example, the abundance of Actinobacteria and Bacteroidetes would allow
maximisation of energy intake from dietary fibre and would proffer a protective effect on
inflammation influences through the generation of SCFAs [107]; see Figure 2. Other studies
showing that a postweaning diet impacts the infant gut microbiota include a recent study
in Australian children (age 1 to 2 years), which showed the consumption of meat/fish
and fruit (unprocessed foods) to be positively associated with Bacteroidetes (Bacteroides
thetaiotaomicron) as well as Ruminococcus, Lachnospiraceae and Bacteroides species [108].
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There is thus considerable evidence indicating that the composition of the gut micro-
biota of children adapts to the diet, and this would be expected to have an impact on the
metabolic performance of the gut microbiota as well as on the health of the child [93]. This
suggests that a deeper understanding of how diet affects the gut microbiota of infants and
young children could lead to innovative approaches for improving health and may pave
the way for new strategies for fighting malnutrition in children.
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4. The Gut Microbiota and Malnutrition in Young Children
4.1. Malnutrition
Malnutrition is the condition where there is an imbalance in the nutrient/energy
intake of an individual resulting from insufficient or excess consumption of nutrients.
Malnutrition presents in several forms, including undernutrition (underweight, wasting,
stunting, and micronutrient deficiency including vitamin and mineral deficiencies) and
overnutrition (overweight and obesity) [109]. There are three main ways to assess the
nutritional status of children. One involves anthropometric measurements, which include
weight, height or length, mid-upper arm circumference and head circumference [109].
These are used to determine macronutrient malnutrition (related to carbohydrates, proteins
and fats), especially in children. Other methods utilise clinical symptoms, such as presence
or absence of bilateral oedema, to determine malnutrition. A further approach is the use
of biochemical methods (such as haemoglobin, blood ferritin and retinol-binding protein
levels), which are particularly useful in diagnosis of micronutrient malnutrition. Although
clinical signs can indicate micronutrient malnutrition, biochemical tests are used to confirm
or determine specific micronutrient deficiencies [110]. There are three main indices of
malnutrition:
(i). Weight-for-age (underweight) is, as the name implies, a measure of the child’s weight
relative to their age compared to the WHO growth standard reference. Children
whose weight-for-age falls more than two or three standard deviations (SD) below
the average are classified as being underweight or severely underweight, respec-
tively [109].
(ii). Height-for-age (stunting) is a measure of the height of the child relative to the age
compared to the WHO’s growth standards reference for children of the same age and
sex. Children whose height-for-age Z-score is two or three SD below the average are
classified as moderately or severely stunted, respectively [109]. This is a measure of
long-term nutritional deficiency.
(iii). Weight-for-height (wasting) measures acute malnutrition in children. It is the weight
of the child compared to that of standard reference weights of healthy children of
the same sex and height [109]. This is an indicator of recent or recurrent infections or
diarrhoea because diarrhoea causes rapid weight loss, especially in children [111].
4.2. Causes of Malnutrition
Malnutrition is caused by different factors and, according to UNICEF 1990, these can
be grouped into three main categories: (i) immediate causes, (ii) underlying causes and
(iii) basic causes. The immediate causes are inadequate dietary intake and illness (e.g.,
diarrhoea). The underlying causes of malnutrition are household food insecurity, poor
maternal and childcare practices, poor access to health and poor sanitation. These are
factors that directly cause inadequate dietary intake and diseases among children. The
basic causes, also known as root causes, are the resources, political, cultural and economic
structures in the area [2].
4.3. Gut Microbiota in Malnutrition
Until a few decades ago, inadequate food intake and disease were the two recognised
immediate causes of malnutrition, but enteric infections such as diarrhoea have since
been reported to be a factor in a significant proportion of global malnutrition cases in
children [112], suggesting a link between diarrhoea and malnutrition as caused by changes
in the gut microbiota (see Figure 2).
Diarrhoea illness can lead to malnutrition through reduced nutrient absorption and
mucosal damage, as well as through nutrient depletion associated with each episode of
diarrhoea [112]. Diarrhoea in children leads to reduced weight and height gains, especially
in children with recurrent diarrhoea. Several studies have shown that there are changes in
the gut microbiota during and after diarrhoea illnesses [113–115]. For instance, consistent
elevation of Fusobacterium mortiferum, Escherichia coli and oral microorganisms in the faecal
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microbiome of children (1–6 years old) suffering from diarrhoea have been reported [113].
Moreover, in a one-year cohort study of diarrhoea aetiologies in children [116], Fusobac-
terium from the phylum Fusobacteria was overrepresented in stool samples of diarrhoeal
children compared to children who were recovering. In addition, a high relative abundance
of Bacteroides in diarrhoea compared to recovery stools was observed [116]. Moreover, data
from the Global Enterics Multicenter Study (GEMS) in West and East Africa, and Southeast
Asia suggested that moderate-to-severe diarrhoea in children leads to reduced bacterial
diversity and altered microbiota composition [117]. It was also reported that diarrhoea in
children under 2 years of age from resource-poor areas may lead to decreased height (on
average, 8 cm shortfall) and a decrease of 10 intelligence quotient (IQ) points by the age
of 7 to 9 years [118]. As such, malnutrition-induced decreases in IQ are likely to impact
quality of life in many ways, which could be countered by controlling diarrhoea and other
factors associated with childhood malnutrition.
The above observations suggest that children suffering from diarrhoea during early
life may suffer impairments in gut microbiota development that could result in persistent
diarrhoea, leading to stunting, reduced IQ and growth faltering. Therefore, it is possi-
ble that pre- and probiotic interventions may help to support the microbiota to combat
diarrhoea and offer some benefits against malnutrition [119]. The use of prebiotics may
be of particular benefit to the management of SAM where children receive antibiotics as
part of the treatment process. Prebiotics have been shown to reduce the adverse effects of
antibiotics on the gut microbiota [120]; however, further research is needed with regards to
their impact in the treatment of malnutrition.
It has been reported that certain subclinical alterations in the gut microbiome can
lead to stunting even in the absence of obvious infections such as diarrhoea [121–123]. For
instance, poor sanitary conditions whereby there is chronic exposure to environmental
pathogens resulting in subclinical alteration in the gut microbiota structure and function
have been proposed to cause stunting [124,125]. This has been termed environmental
enteric dysfunction (EED). EED is defined as an acquired subclinical disorder of the small
intestine, marked by villous atrophy and crypt hyperplasia. EED often affects children in
resource-poor countries [121] and may contribute to stunting. In Gambian infants, faecal
neopterin, which has been linked with cell-mediated inflammation and a marker of EED,
was negatively associated with weight and height gain [126]. Consistently, a pilot study
conducted in eight different countries observed a significant association between faecal
neopterin, myeloperoxidase and alpha-1-antitrypsin, and a decrease in length-for-age
z-scores (an indicator of stunting in children) [127].
Recent advances in understanding of the gut microbiome have revealed that the gut
microbiota may be a contributor to undernutrition (see [10] for a recent review). In a longi-
tudinal study [3], the gut microbiota of Malawian twins was associated with kwashiorkor
(a form of severe acute malnutrition). Further, the gut microbiota of children who became
malnourished in their first 3 years was poorly matured (in terms of microbial diversity)
and different to that of healthy children (see Table 1). When applied to gnotobiotic mice,
the combination of Malawian diet and kwashiorkor microbiota caused severe weight loss
(about 35% weight loss from the initial body weight), suggesting a causal relationship
between the gut microbiota and malnutrition. In addition, several studies in children from
sub-Saharan Africa, India and Bangladesh have reported decreased bacterial diversity in
faecal samples of children suffering malnutrition with increases in Proteobacteria, Bac-
teroidetes and anaerobic Firmicutes [128–132]. Consistent with these findings, it was also
observed that Proteobacteria dominate the gut microbiota of hospitalized malnourished
children in Uganda [133], as can be seen in Table 1. Moreover, in low-income countries, the
prevalence of stunting increases in children of ages between 6 and 59 months [134–136],
which corresponds to the period that directly follows the introduction of complementary
feeding when the gut microbiota undergoes a major change in composition. The introduc-
tion of complementary feeding also increases the risk of diarrhoea, a risk factor for stunting,
especially in resource-poor communities where high diarrhoea incidence is combined with
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inadequate nutrient intake [135,136]. Indeed, there is evidence to suggest that differences
in the gut microbiota of infants in developing countries are associated with diarrhoea,
which increases the risk of malnutrition (wasting and stunting) and mortality in affected
children [123,137–140]. The first step in the dysbiosis of the gut microbiota during malnu-
trition in children is thought to be the depletion in bifidobacteria, which is followed by the
colonization by potential microbial pathogens (Streptococcus spp., Fusobacterium mortiferum
and Escherichia coli), causing diarrhoea and malabsorption of essential nutrients [116,128].
A similar depletion of beneficial species, and increase in potentially harmful species, was
reported more recently, showing that malnourished children suffer a consistent reduction
of species from the families Bacteroidaceae, Ruminococceae, Eubacteriaceae and Lach-
nospiroceae with an enrichment of the species Staphylococcus aureus, Escherichia coli and
Enterococcus faecalis [141]. Moreover, it was shown that malnutrition in children is linked to
reduction in the species Bifidobacterium longum and Lactobacillus mucosae [142].
It remains unclear whether the observed microbial differences contribute to malnu-
trition or whether the malnutrition is the cause of these changes, although experiments
in mice demonstrated that a gut microbiota with relatively high differential abundance
of Bilophila wadsworthia and Clostridioides innocuum combined with a low-nutrient diet en-
hanced malnutrition [3], which provides evidence of a role for the microbiota in mediating
malnutrition. It must be noted that there is some variation in the gut microbiota alter-
ations reported in different populations. However, those groups of bacteria consistently
reported to decrease during malnutrition include Bifidobacterium spp., Lactobacillus spp.,
Ruminococcus spp. and Faecalibacterium prausnitzii, whilst those consistently reported to
increase include Bacteroidetes, Clostridioides innocuum, Streptococcus spp. and Escherichia
spp. (see Figure 1 for summary of bacteria consistently shifting during malnutrition).
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Table 1. Summary of the main findings of studies on infant and young child gut microbiota alteration during malnutrition.
Author(s), Subjects and Country Study Design Method of Analysis Dietary Intervention Main Findings
Smith, Yatsunenko [3]




until 36 months old) and
transplantation of GM from
twin pairs discordant for




SAM children received ready-to-use
therapeutic food (RUTF) and MAM
received soy–peanut ready-to-use
supplementary food.
GF mice were given Malawian diet
followed by RUTF
RUTF resulted in the maturation of the SAM
microbiota with increases in Bifidobacterium,
Ruminococcus, Faecalibacterium prausnitzii and
Lactobacillus spp. and reduction in the members of
the Bacteriodetes.
Bilophila wadsworthia (Proteobacteria, Desulfovibrio) and
Clostridioides innocuum were associated with
kwashiorkor (SAM) microbiota
Subramanian, Huq [106]
64 SAM children 6–20 months oldBangladesh Randomised intervention study
16S rRNA amplicon
sequencing
RUTF compared to locally produced
therapeutic food (Khichuri-Halwa) made
from rice and lentils
Microbiota diversity inversely and significantly
associated with Weight-for-Height Z-score (WHZ).
SAM children had less diverse microbiota
Gough, Stephens [143]
18 Malawian twin pairs cohort and 11
Bangladeshi cohort
Malawi and Bangladesh








Malawian cohort: not available
Bangladeshi cohort: RUTF
Stunting severity (SAM) was associated with reduced
gut microbiota diversity. In both cohorts, linear
future growth is associated with relative abundance
of Acidaminococcus spp.
Bangladeshi cohort: largest decreases in relative
abundance of Dorea, Lactobacillus, Blautia, Olsenella
and other unclassified genera in the Enterococcaceae
and Coriobacteriaceae in cases vs. controls whilst in the
Malawian cohort, there were significant decreases
observed in Eubacterium, Prevotella, Blautia and
Bacteroides in cases vs. controls.
Ghosh, Sen Gupta [128]
20 children ages 5 to 60 months old
India
Cross-sectional study 16S DNA large-scalesequencing No specific dietary intervention
Borderline and severely malnourished children’s gut
microbiota is characterised by increased abundance
of Shigella, Enterobacter, Veillonella, Escherichia,
Streptococcus and Faecalibacterium. Roseburia and
Butyrivibrio characterised the gut microbiota of
healthy children.
Monira, Nakamura [129]
7 healthy and 7 SAM children (ages 2 to 3 years
old)
Bangladesh
Cross-sectional study 16S rRNA ampliconsequencing (V5–V6 regions)
Both groups given normal Bangladeshi
diet
SAM: the phyla Bacteroidetes and Proteobacteria
accounted for 18% and 46%, respectively, of bacteria
population
Healthy: 44% and 5% Bacteroidetes and
Proteobacteria, respectively
Kristensen, Wiese [133]
87 hospitalised SAM children (ages 6–24







F75 and F100 during the stabilization
phase and RUTF during rehabilitation
phase
Proteobacteria dominated the gut microbiota of
hospitalized oedematous and non-oedematous SAM
children and alpha diversity higher in only
oedematous SAM children
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Table 1. Cont.
Author(s), Subjects and Country Study Design Method of Analysis Dietary Intervention Main Findings
Million, Tidjani Alou [141]
86 SAM from Senegal (n = 32) and Niger (n =
54)
Also included a meta-analysis of 184 children
from 5 studies (107 SAM; 77 healthy)
Malawi, Bangladesh, Senegal, Niger and India
Case-control study 16S rRNA ampliconsequencing (V3–V4 regions)
Dietary intervention in Senegal was an
energetic milk made of milk, oil and
sugar. In Niger, children did not receive
dietary treatment before recruitment
In SAM cases, there was depletion of several obligate
anaerobes, including Bacteroidaceae, Ruminococcaceae,
Eubacteriaceae, Lachnospiraceae, Erysipelotrichaceae,
Coriobacteriaceae and Eggerthella.
Additionally, enrichment in potential pathogenic
bacteria species, including Staphylococcus aureus,
Enterococcus faecalis and Escherichia coli, observed in
SAM children
Dinh, Ramadass [142]
10 low-birth-weight children with persistent
stunting (SAM), compared to 10
normal-birth-weight children (healthy with no
stunting controls), followed till 2 years of age
India
Longitudinal case control 16S rRNA ampliconsequencing (V4 region)
All children were breastfed for varying
periods, complementary foods consisted
of mainly rice, lentils and vegetables
There was higher relative abundance of the phylum
Bacteroidetes in the stunted (SAM) children
compared with control children at 12 months of age.
The stunted (SAM) children’s microbiota was
enriched with Desulfovibrio genus and
Campylobacterales order, whereas the controls had
enrichment in potentially probiotic species
Bifidobacterium longum and Lactobacillus mucosae.
Tidjani, Million [132]
10 SAM children with oedema and 5 healthy
children (2 to 38 months old)
Senegal and Niger
Cross-sectional study





Significantly, more Streptococcus gallolyticus,
Proteobacteria and Fusobacteria as well as decrease
in diversity of gut microbial population in the SAM
children observed. A total of 45 species of bacteria
identified in healthy children but missing in SAM
microbiota, with 12 species found to have probiotics
potential (Bifidobacterium adolescentis, Anaerostipes
caccae, Bacillus licheniformis, Bacillus subtilis,
Intestinimonas butyriciproducens, Bacteroides salyersiae,
Lactobacillus vaccinostercus, Terrisporobacter glycolicus,
Alistipes indistinctus, Lactobacillus parabuchneri and
Lactobacillus perolens)
Raman, Gehrig [144]
36 members of the Bangladesh birth cohort
Sparse random forests
(RF)-derived model V4-16S rDNA amplicons No intervention
A total of 15 bacteria taxa were identified to be
associated with different degrees of undernutrition
(SAM and moderate acute malnutrition—MAM).
Termed “ecogroup”, the 15 bacteria taxa identified
are S. thermophilus F. prausnitzii (514940 and 851865),
Bifidobacterium, E. coli, Dialister, B. longum, S.
gallolyticus, Prevotella, P. copri (840914 and 588929),
Clostridiales, E. rectale, L. ruminis and E. faecalis.
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Table 1. Cont.




Randomised controlled trial V4-16S rRNA gene sequencing
Microbiota-directed complementary
food-2 compared with ready-to-use
supplementary Food
MDCF-2 produced better outcomes with regards to
wasting and stunting than RUSF did.
MDCF-2 was associated with Faecalibacterium
prausnitzii, Dorea formicigenerans, Ruminococcus gnavus
and a member of Clostridiales previously described as
weight discriminatory taxa
Gehrig, Venkatesh [146]






V4-16S rRNA gene sequencing MDCFs compared with RUSF
Enterococcus avium, Escherichia fergusonii,
Bifidobacterium pseudocatenulatum, Streptococcus
constellatus and Streptococcus pasteurianus were
characteristic of malnourished microbiota.
MDCF-2 was shown to increase the relative
abundance of F. prausnitzii, Clostridiales sp., and
decrease the abundance of B. longum.
MDCF-2 shifted the plasma proteome of MAM
toward a healthy one and improved growth
parameters in MAM
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In summary, the available evidence indicates a clear relationship between the gut
microbiota and malnutrition. Thus, it is now recognized that malnutrition in children is
linked to altered development and maturity of the gut microbiota, and as such, this is a
functional target that should be explored in the fight against malnutrition [147].
4.4. Treatment of Malnourished Children with RUTF/MDCF Impacts the Gut Microbiota
Although the approach used to treat malnutrition in children varies from country
to country, ready-to-use therapeutic foods (RUTF, a peanut-paste mixed with milk and
vegetable oil, and fortified with vitamins and minerals that is used to treat children with
severe acute malnutrition) has revolutionized the treatment of SAM during both in- and
outpatient care [148,149]. In line with the recommendations of WHO inpatient treatment
of SAM, a milk-based formula (F75) is used for the stabilization phase of treatment before
energy/micronutrient-dense RUTF treatment is initiated. For community-based treatment
of moderate acute malnutrition (MAM), ready-to-use supplementary foods (RUSF) are used.
Over the years, compared to homemade formulae RUTF has been observed to be a more
effective treatment for children with SAM. This has been reported in a recent randomized
controlled trial in malnourished Ghanaian children, where standard RUTF treatment
resulted in significant recovery (in terms of weight and mid-upper arm circumference)
compared to locally formulated RUTF [150]. It was further shown that RUTF treatment of
kwashiorkor-suffering Malawian twins from birth until 3 years resulted in the maturation
of the microbiota with increases in Bifidobacterium, Ruminococcus, Faecalibacterium prausnitzii
and Lactobacillus spp. and reduction in the members of the Bacteroidetes [3]. These changes
are predicted to protect against enteropathogens by contributing to the production of
bacteriocins and supporting the stimulation of the immune system. Such changes were
only partially maintained once RUTF was withdrawn. The findings are consistent with
results from a Bangladeshi study that examined the microbiota of malnourished and
healthy children in an attempt to define gut microbiota maturation over the first 3 years of
life [106]. Treatment of malnourished children with either RUTF or a locally made formula
(made from rice, wheat flour, lentils, green leafy vegetables and soybean oil) resulted in a
more diverse and mature microbiota, which regressed when treatment was stopped. In
addition, a time series metagenomic analysis of faecal samples collected from the above
Malawian study [3] showed lower gut microbial diversity in the SAM children compared
with their healthy siblings. In contrast to these studies, a clinical study observed that RUTF
treatment of kwashiorkor-suffering malnourished children from birth until 3 years of age
did not lead to significant changes in gut microbiota diversity and composition [130].
A recent study comparing the effects of two “microbiota-directed complementary
foods” (MDCF) and RUTF formulae in Bangladeshi children recovering from SAM con-
firmed the underdeveloped (immature) nature of the gut microbiome in SAM and post-
SAM, MAM children (in comparison with an age-matched control group) [146]. This study
further showed that an “optimized” MDCF formula (MDCF-2; containing flour made from
chickpea, soyabean, green banana and peanut) can improve a range of growth and other
health indicators in MAM children towards the status of healthy controls; this effect was
associated with changed abundance of three bacteria most strongly associated with gut
microbiota maturation (i.e., increased abundance of F. prausnitzii and Clostridioides spp.,
and decreased B. longum). A more recent randomized control trial further compared the
effect of MDCF-2 and RUSF on growth and health recovery in MAM Bangladeshi children.
This research confirmed that MDCF-2 treatment supports growth recovery of MAM chil-
dren, which was linked to corresponding changes in the faecal microbiota abundance of
23 weight-discriminatory taxa [145]. The above reports suggest that MDCF treatment can
support the gut microbiota of malnourished children. Thus, dietary targets that impact
the microbiota are worthy of study in order to identify factors that counter malnutri-
tion through microbiota-driven effects. Table 1 summarises the studies (as discussed in
this review) on alterations of the gut microbiota of infants and young children during
malnutrition.
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An important implication of the above studies is that the beneficial changes of dietary
interventions (such as RUTF) on the gut microbiota in the treatment of SAM are not
sustained once treatment is withdrawn, and further work is required to confirm any
beneficial long-term impact of such interventions relating to the gut microbiota of SAM
children. However, the recent findings that MDCFs have the potential to “repair” the
gut microbiota impairments of childhood malnutrition, leading to improved growth and
development, raise the promise of improved future intervention strategies.
In summary, there is evidence, albeit limited [128–131], that directly links negative
changes in the gut microbiota to malnutrition in children, which in turn raises the possibility
of a relationship that could be manipulated to better manage health. Additionally, MDCF
treatment of malnutrition presents a great opportunity, and clinical studies in different
populations are warranted to confirm the effectiveness of this strategy. Further, although
RUTF treatment results in good nutritional outcomes (anthropometric indices), there is
limited data on the effect of RUTF treatment on the gut microbiota of malnourished children,
indicating that more research is needed in this area.
5. Conclusions
In conclusion, diet is a strong modifier of the gut microbiota, especially in young
children whose microbiota is subject to rapid changes. There is strong evidence linking the
gut microbiota composition to malnutrition in children. Therefore, future interventions
that support a healthy microbiota in malnourished children should be investigated as a tool
to help to combat malnourishment. Any advancement in combating malnutrition would
be particularly relevant to children in sub-Saharan Africa and Asia where the prevalence of
malnutrition continues to threaten the lives of millions of children.
Future Direction
Targeting the gut microbiota, such as through the use of prebiotics, as part of the
treatment of childhood malnutrition could present an effective, affordable and sustainable
strategy in the treatment and/or prevention of SAM. Fortifying the microbiota in this way
could enhance energy salvaging and may protect against diarrhoea. However, clinical
evidence that can be translated into clinical practice is lacking. Therefore, studies on the
impact of prebiotics on the gut microbiota and its influence on nutrition outcomes in
children suffering from malnutrition are needed.
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